May 12, 2009Drug Shortages: Current Drug Shortages: Cisplatin Injection 1mg/ml (updated) Drug Shortages: Current Drug Shortages: Cisplatin Injection 1mg/ml (updated)
Current Drug Shortages: Cisplatin Injection 1mg/ml : See updated Related Information Section for Teva Source: www.fda.gov Guidance for Industry Individual Product Bioequivalence Recommendations Source: www.fda.gov Efalizumab (marketed as Raptiva) Information Efalizumab (marketed as Raptiva) Information Source: www.fda.gov Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conductedf under Section 505A and 505B of the FDA (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA) Source: www.fda.gov Approved Drug Products with Therapeutic Equivalence Evaluations Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations Orange Book Source: www.fda.gov Drug Shortages: Current Drug Shortages: Metoprolol succinate extended release tablets (updated) Current Drug Shortages: Metoprolol succinate extended release tablets: See updated letter in Related Information Section Source: www.fda.gov FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic and Myobloc FDA updates the Early Communication about an Ongoing Safety Review of Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B) Source: www.fda.gov Guidance for Industry Submission of Summary Bioequivalence Data for ANDAs Source: www.fda.gov Paragraph IV Patent Certifications Office of Generic Drugs: Paragraph IV Patent Certifications (updated) Source: www.fda.gov # posted by Network @ 10:08 PM
 |
Subscribe to Posts [Atom]